These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9606814)

  • 21. Bile duct epithelial cell culture.
    Sirica AE
    Methods Mol Biol; 2002; 188():37-52. PubMed ID: 11987558
    [No Abstract]   [Full Text] [Related]  

  • 22. Biliary bicarbonate secretion constitutes a protective mechanism against bile acid-induced injury in man.
    Hohenester S; Maillette de Buy Wenniger L; Jefferson DM; Oude Elferink RP; Beuers U
    Dig Dis; 2011; 29(1):62-5. PubMed ID: 21691107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholangiocyte biology.
    Bogert PT; LaRusso NF
    Curr Opin Gastroenterol; 2007 May; 23(3):299-305. PubMed ID: 17414846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
    Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
    Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-stranded RNA activates a p38 MAPK-dependent cell survival program in biliary epithelia.
    Tadlock L; Yamagiwa Y; Marienfeld C; Patel T
    Am J Physiol Gastrointest Liver Physiol; 2003 Jun; 284(6):G924-32. PubMed ID: 12540369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biliary differentiation and bile duct morphogenesis in development and disease.
    Raynaud P; Carpentier R; Antoniou A; Lemaigre FP
    Int J Biochem Cell Biol; 2011 Feb; 43(2):245-56. PubMed ID: 19735739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cholangiocarcinoma growth by tannic acid.
    Marienfeld C; Tadlock L; Yamagiwa Y; Patel T
    Hepatology; 2003 May; 37(5):1097-104. PubMed ID: 12717390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.
    Roskams T
    Oncogene; 2006 Jun; 25(27):3818-22. PubMed ID: 16799623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand.
    Humphreys EH; Williams KT; Adams DH; Afford SC
    PLoS One; 2010 Nov; 5(11):e14037. PubMed ID: 21103345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and antitumor effects of TRAIL in human cholangiocarcinoma.
    Tanaka S; Sugimachi K; Shirabe K; Shimada M; Wands JR
    Hepatology; 2000 Sep; 32(3):523-7. PubMed ID: 10960444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrahepatic cholangiocarcinoma: current surgical strategy.
    Boutros C; Somasundar P; Espat NJ
    Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of biliary cholangiocarcinoma cell apoptosis by 103Pd cholangial radioactive stent gamma-rays.
    He GJ; Sun DD; Ji DW; Sui DM; Yu FQ; Gao QY; Dai XW; Gao H; Jiang T; Dai CL
    Chin Med J (Engl); 2008 Jun; 121(11):1020-4. PubMed ID: 18706251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholangiocyte injury and ductopenic syndromes.
    Xia X; Demorrow S; Francis H; Glaser S; Alpini G; Marzioni M; Fava G; Lesage G
    Semin Liver Dis; 2007 Nov; 27(4):401-12. PubMed ID: 17979076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement.
    Zen Y; Aishima S; Ajioka Y; Haratake J; Kage M; Kondo F; Nimura Y; Sakamoto M; Sasaki M; Shimamatsu K; Wakasa K; Park YN; Chen MF; Atomi Y; Nakanuma Y
    Pathol Int; 2005 Apr; 55(4):180-8. PubMed ID: 15826244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Cholangiopathies.
    Lazaridis KN; LaRusso NF
    Mayo Clin Proc; 2015 Jun; 90(6):791-800. PubMed ID: 25957621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma.
    Lie-A-Ling M; Bakker CT; Deurholt T; Hoekstra R; Wesseling JG; Afford SC; Bosma PJ
    J Hepatol; 2006 Jan; 44(1):126-33. PubMed ID: 16168519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transpapillary biliary biopsy for early stage cholangiocarcinoma of the distal common bile duct.
    Asada M; Yazumi S; Yoshimoto T; Tamaki H; Matsuura M; Hasegawa K; Uenoyama Y; Hisatsune H; Nishio A; Chiba T
    Gastrointest Endosc; 2006 Jul; 64(1):125-6; discussion 126. PubMed ID: 16813820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.